Pacific Edge Limited

PINK:PFGTF USA Diagnostics & Research
Market Cap
$80.76 Million
Market Cap Rank
#19746 Global
#7233 in USA
Share Price
$0.08
Change (1 day)
+0.00%
52-Week Range
$0.08 - $0.11
All Time High
$1.20
About

Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic produc… Read more

Pacific Edge Limited (PFGTF) - Total Assets

Latest total assets as of September 2025: $34.41 Million USD

Based on the latest financial reports, Pacific Edge Limited (PFGTF) holds total assets worth $34.41 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Pacific Edge Limited - Total Assets Trend (2005–2025)

This chart illustrates how Pacific Edge Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Pacific Edge Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Pacific Edge Limited's total assets of $34.41 Million consist of 83.2% current assets and 16.8% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 61.0%
Accounts Receivable $4.97 Million 13.4%
Inventory $1.61 Million 4.3%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $781.00K 2.1%
Goodwill $0.00 0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Pacific Edge Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Pacific Edge Limited's current assets represent 83.2% of total assets in 2025, an increase from 20.3% in 2005.
  • Cash Position: Cash and equivalents constituted 61.0% of total assets in 2025, up from 16.5% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 45.0% in 2005.
  • Asset Diversification: The largest asset category is accounts receivable at 13.4% of total assets.

Pacific Edge Limited Competitors by Total Assets

Key competitors of Pacific Edge Limited based on total assets are shown below.

Company Country Total Assets
ADCNF
OTCGREY:ADCNF
USA $4.51 Billion
Berry Genomics Co Ltd
SHE:000710
China CN¥2.34 Billion
Malaysian Genomics Resource
KLSE:0155
Malaysia RM20.70 Million
NSN Co. Ltd
KQ:031860
Korea ₩60.96 Billion
JOONGANG DNM Co.Ltd
KQ:051980
Korea ₩121.79 Billion
GeneMatrix Inc
KQ:109820
Korea ₩28.03 Billion
Genoray Co. Ltd
KQ:122310
Korea ₩125.67 Billion
Green Cross Lab Cell Corporation
KQ:144510
Korea ₩565.79 Billion

Pacific Edge Limited - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.07 - 0.59

Moderate asset utilization - Pacific Edge Limited generates 0.59x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -108.16% - -15.95%

Negative ROA - Pacific Edge Limited is currently not profitable relative to its asset base.

Pacific Edge Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.10 5.26 7.73
Quick Ratio 3.83 5.10 7.54
Cash Ratio 0.00 0.00 0.00
Working Capital $22.20 Million $ 35.88 Million $ 28.29 Million

Pacific Edge Limited - Advanced Valuation Insights

This section examines the relationship between Pacific Edge Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 11.13
Latest Market Cap to Assets Ratio 1.87
Asset Growth Rate (YoY) -43.4%
Total Assets $37.03 Million
Market Capitalization $69.34 Million USD

Valuation Analysis

Above Book Valuation: The market values Pacific Edge Limited's assets above their book value (1.87 x), reflecting positive investor sentiment about the company's future prospects.

Significant Asset Reduction: Pacific Edge Limited's assets decreased by 43.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Pacific Edge Limited (2005–2025)

The table below shows the annual total assets of Pacific Edge Limited from 2005 to 2025.

Year Total Assets Change
2025-03-31 $37.03 Million -43.42%
2024-03-31 $65.45 Million -32.61%
2023-03-31 $97.12 Million -21.69%
2022-03-31 $124.03 Million +297.72%
2021-03-31 $31.18 Million +61.34%
2020-03-31 $19.33 Million +16.67%
2019-03-31 $16.57 Million -15.76%
2018-03-31 $19.66 Million -16.54%
2017-03-31 $23.56 Million -27.12%
2016-03-31 $32.33 Million +155.92%
2015-03-31 $12.63 Million -44.42%
2014-03-31 $22.73 Million +85.97%
2013-03-31 $12.22 Million -34.45%
2012-03-31 $18.65 Million +465.91%
2011-03-31 $3.29 Million +82.95%
2010-03-31 $1.80 Million +100.87%
2009-03-31 $896.61K -71.79%
2008-03-31 $3.18 Million +464.59%
2007-03-31 $562.96K -56.52%
2006-03-31 $1.29 Million -6.38%
2005-03-31 $1.38 Million --